Internal Medicine, Endocrinology, Diabetes, & Metabolism · Renton, WA
NPI
1992835607
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
660 SW 39th St, Ste 150
Renton, WA, 98057
Phone (425) 793-4700
Groups this clinician bills Medicare through
Medicare paid, 2024
$78K
1,520 services
Medicare patients, 2024
325
Average age 74
Drug cost, 2024
$2.8M
6,315 prescriptions
Company payments, 2023
$35.91
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Theresa N Tran was code 99214 (office e&m - established), 484 times for 266 patients. In total Theresa N Tran billed 1,520 services in 23 codes, and Medicare paid $78K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-11-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 484 | 266 | $94.85 | $46K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 340 | 233 | $13.24 | $4,502 |
| 95251 Test - Miscellaneous | Office | 317 | 135 | $26.17 | $8,296 |
| 82962 Clinical Chemistry | Office | 139 | 86 | $3.12 | $434 |
| 99215 Office E&M - Established | Office | 56 | 44 | $134.73 | $7,545 |
| 99426 Chronic, Principal, and Transitional Care Management | Office | 39 | 11 | $53.50 | $2,087 |
| G0008 Administration of influenza virus vaccine | Office | 29 | 29 | $35.62 | $1,033 |
| 90662 Vaccine Product | Office | 20 | 20 | $41.16 | $823 |
| 95249 Test - Miscellaneous | Office | 18 | 18 | $48.07 | $865 |
| 99204 Office E&M - New | Office | 18 | 18 | $136.94 | $2,465 |
| 99213 Office E&M - Established | Office | 16 | 16 | $64.33 | $1,029 |
| 99451 E&M - Miscellaneous | Office | 15 | 15 | $26.25 | $394 |
By year: 2022 $110K for 5,610 services; 2023 $103K for 5,536 services; 2024 $78K for 1,520 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 139 | 86 | $3.12 | $434 |
Medicare prescription drug claims, 2024
In 2024, the drug Theresa N Tran prescribed most often to Medicare patients was Levothyroxine Sodium, with 565 prescriptions and refills. In total Theresa N Tran wrote 6,315 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 565 | 1,555 | 149 | $5,056 |
| Ozempic Semaglutide | 435 | 759 | 95 | $716K |
| Atorvastatin Calcium Generic | 415 | 1,188 | 126 | $4,873 |
| Jardiance Empagliflozin | 357 | 873 | 93 | $506K |
| Metformin Hcl Er Metformin Hcl | 283 | 793 | 81 | $3,226 |
| Metformin Hcl Generic | 272 | 776 | 75 | $2,453 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 230 | 662 | 80 | $41K |
| Glipizide Generic | 138 | 392 | 44 | $1,605 |
| Methimazole Generic | 137 | 369 | 39 | $969 |
| Humalog Kwikpen U-100 Insulin Lispro | 129 | 321 | 44 | $69K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 121 | 322 | 49 | $14K |
| Novolog Flexpen Insulin Aspart | 119 | 321 | 52 | $60K |
| Lisinopril Generic | 109 | 323 | 36 | $1,167 |
| Rosuvastatin Calcium Generic | 102 | 290 | 30 | $1,624 |
| Trulicity Dulaglutide | 95 | 148 | 21 | $146K |
Brand drugs: 2,765 claims; generic drugs: 3,026 claims.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Theresa N Tran $35.91 ($35.91 in general payments such as food, travel and fees) from 2 companies. The largest payer was Abbott Laboratories with $21.32.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 1 | $21.32 |
| Antares Pharma, Inc. | 1 | $14.59 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.